You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Colorcon
Medtronic
Harvard Business School
Mallinckrodt

Last Updated: March 28, 2020

DrugPatentWatch Database Preview

IPRATROPIUM BROMIDE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Ipratropium Bromide patents expire, and when can generic versions of Ipratropium Bromide launch?

Ipratropium Bromide is a drug marketed by Actavis Mid Atlantic, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb Inc, Landela Pharm, Mylan Speciality Lp, Nephron, Pharmascience Inc, Ritedose Corp, Roxane, Sun Pharm, Teva Pharms Usa, Watson Labs, Bausch And Lomb, and Hikma. and is included in twenty-one NDAs.

The generic ingredient in IPRATROPIUM BROMIDE is ipratropium bromide. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ipratropium bromide profile page.

US ANDA Litigation and Generic Entry Outlook for Ipratropium Bromide

A generic version of IPRATROPIUM BROMIDE was approved as ipratropium bromide by RITEDOSE CORP on January 26th, 2001.

  Start Trial

Drug patent expirations by year for IPRATROPIUM BROMIDE
Drug Sales Revenue Trends for IPRATROPIUM BROMIDE

See drug sales revenues for IPRATROPIUM BROMIDE

Recent Clinical Trials for IPRATROPIUM BROMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of MonastirPhase 1
Wuhan Union Hospital, ChinaPhase 4
London Health Sciences CentrePhase 2

See all IPRATROPIUM BROMIDE clinical trials

Recent Litigation for IPRATROPIUM BROMIDE

Identify potential future generic entrants

District Court Litigation
Case NameDate
ORTHO-MCNEIL PHARMACEUTICAL, INC. v. LUPIN PHARMACEUTICALS, INC.2006-10-17

See all IPRATROPIUM BROMIDE litigation

Pharmacology for IPRATROPIUM BROMIDE
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for IPRATROPIUM BROMIDE
Synonyms for IPRATROPIUM BROMIDE
(1R,3r,5S)-3-(3-hydroxy-2-phenylpropanoyloxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide
(1R,5S)-3-((3-hydroxy-2-phenylpropanoyl)oxy)-8-isopropyl-8-methyl-8-azabicyclo[3.2.1]octan-8-ium bromide
(1S,3S,5R)-3-Tropyloxy-8-isopropyltropanium bromide
(3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide
(8r)-3-alpha-Hydroxy-8-isopropyl-1-alpha-H,5-alpha-H-tropiumbromide-(+-)-tropate
(endo,Anti)-(1)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo(3.2.1)octane bromide
(endo,syn)-(+-)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide
(exo,Syn)-(1)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo(3.2.1)octane bromide
1-alpha-H,5-alpha-H-Tropanium, 3-alpha-hydroxy-8-isopropyl-, bromide, (+-)-tropate
22254-24-6
24358-20-1
3-alpha-Hydroxy-8-isopropyl-1-alpha-H,5-alpha-H-tropanium bromide (+-)-tropate
3alpha-hydroxy-8-isopropyl-1alphaH,5alphaH-tropanium bromide (+-)-tropate
58073-59-9
60251-88-9
8-Azoniabicyclo(3.2.1)octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, bromide, endo-
8-Isopropylnoratropine methobromide
AKOS015895324
AKOS030485952
ATEM
ATROPINE ISOPROPYLBROMIDE
Atrovent
Atrovent Hfa
BDBM50021892
Bromure d'ipratropium
Bromure d'ipratropium [INN-French]
Bromuro de ipratropio
Bromuro de ipratropio [INN-Spanish]
C20H30BrNO3
CHEBI:46659
CHEMBL1464005
DTXSID60858923
EINECS 244-873-8
EINECS 246-197-9
EINECS 261-098-0
EINECS 262-128-5
endo-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo(3.2.1)octane bromide
HMS2234J05
Ipratropii bromidum
Ipratropii bromidum [INN-Latin]
Ipratropium Bromide (anhydrous)
Ipratropium bromide [INN]
Ipratropium bromide anhydrous
Ipratropium Bromide'
ipratropium-bromide
Ipratropiumbromid
Ipratropiumbromid [German]
Itrop
MLS000069557
N-Isopropylnoratropinium bromomethylate
N-Isopropylnortropine tropate methobromide
Opera_ID_1621
Prestwick_279
Q424294
REGID_for_CID_657308
SC-14062
Sch 1000
SCHEMBL107906
SCHEMBL16762661
SCHEMBL3852
SCHEMBL3854
SMR000058764
UNII-VJV4X1P2Z1
VJV4X1P2Z1

US Patents and Regulatory Information for IPRATROPIUM BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075111-001 Apr 22, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
Hikma IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 076664-001 Nov 5, 2003 AB RX No Yes   Start Trial   Start Trial   Start Trial
Nephron IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075562-001 Sep 27, 2001 AN RX No No   Start Trial   Start Trial   Start Trial
Bausch And Lomb Inc IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075835-001 Oct 15, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075313-001 Feb 7, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Colorcon
Medtronic
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.